Income Statement ZIM Laboratories Limited

Stocks

ZIMLAB

INE518E01015

Pharmaceuticals

Market Closed - Bombay S.E. Other stock markets 06:00:49 2026-07-17 EDT			5-day change	1st Jan Change
125.45 ^INR	+1.95%		+10.29%	+74.50%

05-21	Dubai Investments says Globalpharma signs 7 strategic MoUs	RE
05-20	ZIM Laboratories Limited, Q4 2026 Earnings Call, May 20, 2026

06f92b65ed.CeKwV0yueKDaiu377VaeC1kQ4Ij9rg6S0YBjvMDvY8k.RabKE3rjP9qyxZqY3CL8MykmtqWKnzni5cxa17aqUfhkpvUQJuE64e3Qgg

Published financial data: ZIM LABORATORIES LIMITED

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2022	2023	2024	2025	2026
Revenues	3.33B	3.99B	3.67B	3.79B	3.74B
Other Revenues, Total	820K	820K	926K	1.02M	-
Total Revenues	3.34B	3.99B	3.68B	3.79B	3.74B
Cost of Goods Sold, Total	1.67B	2.07B	1.82B	1.76B	1.77B
Gross Profit	1.67B	1.91B	1.86B	2.03B	1.97B
Selling General & Admin Expenses, Total	415M	515M	555M	636M	671M
Provision for Bad Debts	547K	-	11.01M	21.27M	7.81M
Depreciation & Amortization - (IS)	160M	175M	160M	201M	200M
Other Operating Expenses	839M	872M	878M	929M	993M
Other Operating Expenses, Total	1.41B	1.56B	1.6B	1.79B	1.87B
Operating Income	250M	353M	257M	246M	103M
Interest Expense, Total	-71.69M	-49.7M	-58.82M	-94.72M	-121M
Interest And Investment Income	2.9M	3.42M	1.36M	3.33M	3.34M
Net Interest Expenses	-68.79M	-46.28M	-57.46M	-91.39M	-117M
Currency Exchange Gains (Loss)	38.54M	55.49M	38.06M	41.44M	76.78M
Other Non Operating Income (Expenses)	-9.6M	-1.66M	-681K	-14.31M	-5.4M
EBT, Excl. Unusual Items	210M	360M	237M	181M	56.96M
Gain (Loss) On Sale Of Assets	-	-	-156K	-	25.52M
Asset Writedown	-30K	-6.6M	-	-1.37M	-351K
Other Unusual Items	-	-	-	-	-
EBT, Incl. Unusual Items	210M	354M	236M	180M	82.13M
Income Tax Expense	64.92M	109M	63.96M	58.44M	23.75M
Earnings From Continuing Operations	146M	244M	172M	122M	58.38M
Net Income to Company	146M	244M	172M	122M	58.38M
Minority Interest	-	-	1K	2K	-
Net Income - (IS)	146M	244M	172M	122M	58.38M
Net Income to Common Incl Extra Items	146M	244M	172M	122M	58.38M
Net Income to Common Excl. Extra Items	146M	244M	172M	122M	58.38M
Per Share Items
Net EPS - Basic	2.99	5.01	3.54	2.5	1.19
Basic EPS - Continuing Operations	2.99	5.01	3.54	2.5	1.19
Basic Weighted Average Shares Outstanding	48.73M	48.73M	48.73M	48.73M	48.98M
Net EPS - Diluted	2.99	5.01	3.54	2.5	1.19
Diluted EPS - Continuing Operations	2.99	5.01	3.54	2.5	1.19
Diluted Weighted Average Shares Outstanding	48.73M	48.73M	48.73M	48.73M	48.98M
Normalized Basic EPS	2.7	4.62	3.03	2.33	0.73
Normalized Diluted EPS	2.7	4.62	3.03	2.33	0.73
Dividend Per Share	-	-	-	-	-
Payout Ratio	1.15	0.24	0.29	0.47	-
Supplemental Items
EBITDA	388M	499M	391M	396M	248M
EBITA	281M	390M	280M	258M	124M
EBIT	250M	353M	257M	246M	103M
EBITDAR	393M	501M	393M	399M	252M
Total Revenues (As Reported)	3.38B	4.05B	3.73B	3.85B	3.86B
Effective Tax Rate - (Ratio)	30.85	30.89	27.05	32.45	28.91
Total Current Taxes	35.45M	62.91M	8.86M	41.96M	34.27M
Total Deferred Taxes	29.51M	46.3M	54.55M	11.7M	-10.49M
Normalized Net Income	132M	225M	148M	113M	35.6M
Interest on Long-Term Debt	14.4M	3.44M	2.4M	7.75M	5.23M
Non-Cash Pension Expense	494K	-264K	-493K	-237K	3.82M
Supplemental Operating Expense Items
Advertising Expense	9.02M	19.14M	19.11M	25.39M	28.29M
Selling and Marketing Expenses	9.02M	19.14M	19.11M	25.39M	28.29M
Research And Development Expense From Footnotes	169M	187M	196M	-	199M
Net Rental Expense, Total	5.1M	2.23M	2.13M	3.44M	3.94M
Imputed Operating Lease Interest Expense	4.31M	1.53M	1.15M	2.27M	3.11M
Imputed Operating Lease Depreciation	787K	695K	976K	1.17M	824K
Maintenance & Repair Expenses, Total	66.55M	83.91M	101M	79.51M	116M
Stock-Based Comp., SG&A Exp. (Total)	-	-	-	13.54M	11.35M
Stock-Based Comp., Other (Total)	-	-	-	-	-
Total Stock-Based Compensation	-	-	-	13.54M	11.35M

Fiscal Period: March	2022	2023	2024	2025	2026
Assets
Cash And Equivalents	34.2M	64.2M	96M	19.47M	251M
Short Term Investments	-	-	2.84M	900K	151M
Total Cash And Short Term Investments	34.2M	64.2M	98.84M	20.37M	403M
Accounts Receivable, Total	977M	987M	1.03B	1.07B	1.09B
Other Receivables	394K	281K	338K	759K	714K
Notes Receivable	214K	453K	-	-	-
Total Receivables	978M	988M	1.04B	1.07B	1.09B
Inventory	753M	537M	813M	865M	938M
Prepaid Expenses	9.81M	17.55M	18.3M	24M	29M
Restricted Cash	-	-	-	-	-
Other Current Assets, Total	346M	303M	311M	334M	298M
Total Current Assets	2.12B	1.91B	2.28B	2.31B	2.76B
Gross Property Plant And Equipment	1.7B	1.96B	2.68B	2.94B	3.22B
Accumulated Depreciation	-630M	-744M	-873M	-915M	-1.06B
Net Property Plant And Equipment	1.07B	1.22B	1.8B	2.02B	2.15B
Long-term Investments	515K	515K	515K	500K	500K
Goodwill	1.69M	1.69M	1.69M	1.69M	1.69M
Other Intangibles, Total	103M	139M	225M	322M	419M
Deferred Tax Assets Long-Term	-	-	-	-	4.6M
Other Long-Term Assets, Total	121M	149M	160M	59.24M	57.58M
Total Assets	3.42B	3.42B	4.47B	4.72B	5.39B
Liabilities
Accounts Payable, Total	811M	582M	624M	695M	729M
Accrued Expenses, Total	52.41M	83.93M	78.82M	101M	103M
Short-term Borrowings	173M	229M	550M	525M	621M
Current Portion of Long-Term Debt	149M	121M	157M	194M	193M
Current Portion of Leases	14.07M	15.72M	24.72M	35.64M	27.43M
Current Income Taxes Payable	20.66M	-	-	29.2M	25.76M
Unearned Revenue Current, Total	4.48M	3.66M	4.88M	3.85M	-
Other Current Liabilities	234M	72.74M	155M	79.86M	205M
Total Current Liabilities	1.46B	1.11B	1.59B	1.66B	1.9B
Long-Term Debt	189M	246M	356M	403M	416M
Long-Term Leases	7.22M	10.18M	29.5M	20.7M	8.32M
Deferred Tax Liability Non Current	3.63M	48.03M	101M	111M	104M
Total Liabilities	1.66B	1.41B	2.08B	2.2B	2.43B
Common Stock, Total	162M	487M	487M	487M	535M
Additional Paid In Capital	410M	80.3M	80.3M	80.3M	381M
Retained Earnings	1.18B	1.42B	1.58B	1.7B	1.76B
Comprehensive Income and Other	8.23M	19.61M	235M	254M	286M
Total Common Equity	1.76B	2B	2.39B	2.52B	2.96B
Minority Interest	-	-	-	5K	5K
Total Equity	1.76B	2B	2.39B	2.52B	2.96B
Total Liabilities And Equity	3.42B	3.42B	4.47B	4.72B	5.39B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	48.73M	48.73M	48.73M	48.73M	53.5M
ECS Total Common Shares Outstanding	48.73M	48.73M	48.73M	48.73M	53.5M
Book Value / Share	36.06	41.12	49	51.77	55.36
Tangible Book Value	1.65B	1.86B	2.16B	2.2B	2.54B
Tangible Book Value Per Share	33.9	38.23	44.35	45.13	47.48
Total Debt	533M	622M	1.12B	1.18B	1.27B
Net Debt	499M	557M	1.02B	1.16B	863M
Debt Equivalent of Unfunded Proj. Benefit Obligation	-3.86M	-6.67M	-3.3M	-5.54M	-3M
Debt Equivalent Oper. Leases	40.76M	17.82M	17.02M	27.5M	31.49M
Minority Interest, Total (Incl. Fin. Div)	-	-	-	5K	5K
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	414M	362M	497M	567M	585M
Inventories - Work In Process, Total	127M	58.84M	19.72M	74.52M	53.8M
Inventories - Finished Goods, Total	187M	90.04M	270M	202M	284M
Inventories - Others	25.54M	26.2M	26.56M	21.14M	14.69M
Land - (BS)	96.16M	96.16M	96.16M	96.16M	96.16M
Buildings, Total	471M	503M	790M	820M	845M
Machinery, Total	944M	1.02B	1.34B	1.36B	1.43B
Full Time Employees	505	525	556	577	632
Accumulated Allowance for Doubtful Accounts (Supple)	9.03M	16.94M	15.2M	8M	5.68M

Fiscal Period: March	2022	2023	2024	2025	2026
Net Income	146M	244M	172M	122M	58.38M
Depreciation & Amortization - CF	129M	135M	131M	183M	172M
Amortization of Goodwill and Intangible Assets - (CF)	31.03M	37.32M	23.84M	12.67M	21M
Depreciation & Amortization, Total	160M	172M	155M	195M	193M
Amortization of Deferred Charges, Total - (CF)	344K	2.67M	4.76M	5.9M	6.9M
(Gain) Loss From Sale Of Asset	-570K	-200K	-4.7M	-3.35M	-25.17M
Asset Writedown & Restructuring Costs	30K	6.6M	-	1.37M	-
Stock-Based Compensation (CF)	-	-	-	13.54M	11.35M
Provision and Write-off of Bad Debts	547K	7.91M	9.26M	14.07M	5.49M
Other Operating Activities, Total	120M	70.27M	94.09M	167M	85.93M
Change In Accounts Receivable	-19.9M	26.95M	-71.36M	-88.89M	71.28M
Change In Inventories	-209M	216M	-276M	-52.07M	-73.05M
Change In Accounts Payable	295M	-371M	79.08M	37.34M	161M
Change in Other Net Operating Assets	-	-	-	-	-
Cash from Operations	492M	375M	163M	412M	495M
Capital Expenditure	-152M	-367M	-739M	-408M	-444M
Sale of Property, Plant, and Equipment	1.6M	200K	5.48M	7.32M	56.16M
Cash Acquisitions	-	-	-	-	-
Investment in Marketable and Equity Securities, Total	-	-	3.13M	853K	-178M
Other Investing Activities, Total	4.94M	4.44M	493K	534K	1.76M
Cash from Investing	-146M	-362M	-730M	-399M	-563M
Short Term Debt Issued, Total	-	55.92M	322M	-	68.39M
Long-Term Debt Issued, Total	271M	184M	281M	246M	223M
Total Debt Issued	271M	239M	603M	246M	292M
Short Term Debt Repaid, Total	-274M	-	-	-25.26M	-
Long-Term Debt Repaid, Total	-312M	-174M	-147M	-189M	-254M
Total Debt Repaid	-585M	-174M	-147M	-214M	-254M
Issuance of Common Stock	-	-	214M	-	351M
Common Dividends Paid	-1.68M	-585K	-493K	-569K	-
Common & Preferred Stock Dividends Paid	-1.68M	-585K	-493K	-569K	-
Other Financing Activities, Total	-13.38M	-59.5M	-74.64M	-122M	-106M
Cash from Financing	-330M	5.46M	595M	-91.04M	282M
Foreign Exchange Rate Adjustments	3.64M	11.39M	3.8M	2.23M	18.03M
Miscellaneous Cash Flow Adjustments	-	-	-	-	-
Net Change in Cash	20.28M	30M	31.8M	-76.54M	232M
Supplemental Items
Cash Interest Paid	79.26M	55.34M	75.14M	123M	129M
Cash Income Tax Paid (Refund)	4.29M	71.48M	25.84M	-10.76M	37.34M
Levered Free Cash Flow	242M	-139M	-669M	-167M	-154M
Unlevered Free Cash Flow	287M	-108M	-632M	-107M	-78.04M
Change In Net Working Capital	-122M	137M	213M	67.72M	-90.32M
Net Debt Issued / Repaid	-315M	65.54M	456M	31.96M	37.42M

Fiscal Period: March	2022	2023	2024	2025	2026
Profitability
Return on Assets	4.7	6.45	4.07	3.34	1.27
Return on Total Capital	6.63	8.96	5.23	4.26	1.62
Return On Equity %	8.65	13	7.86	4.96	2.13
Return on Common Equity	8.65	13	7.86	4.96	2.13
Margin Analysis
Gross Profit Margin %	49.93	48.01	50.6	53.63	52.74
SG&A Margin	12.44	12.91	15.09	16.79	17.93
EBITDA Margin %	11.63	12.52	10.63	10.43	6.63
EBITA Margin %	8.44	9.78	7.63	6.82	3.31
EBIT Margin %	7.51	8.85	6.98	6.48	2.75
Income From Continuing Operations Margin %	4.36	6.13	4.69	3.21	1.56
Net Income Margin %	4.36	6.13	4.69	3.21	1.56
Net Avail. For Common Margin %	4.36	6.13	4.69	3.21	1.56
Normalized Net Income Margin	3.94	5.65	4.02	2.99	0.95
Levered Free Cash Flow Margin	7.25	-3.49	-18.21	-4.4	-4.1
Unlevered Free Cash Flow Margin	8.59	-2.71	-17.21	-2.83	-2.08
Asset Turnover
Asset Turnover	1	1.17	0.93	0.83	0.74
Fixed Assets Turnover	3.14	3.49	2.43	1.98	1.79
Receivables Turnover (Average Receivables)	3.72	4.06	3.63	3.6	3.47
Inventory Turnover (Average Inventory)	2.58	3.21	2.69	2.1	1.96
Short Term Liquidity
Current Ratio	1.45	1.72	1.43	1.39	1.45
Quick Ratio	0.69	0.95	0.71	0.66	0.78
Operating Cash Flow to Current Liabilities	0.34	0.34	0.1	0.25	0.26
Days Sales Outstanding (Average Receivables)	98.19	89.97	100.71	101.31	105.27
Days Outstanding Inventory (Average Inventory)	141.66	113.6	136.05	174.13	185.9
Average Days Payable Outstanding	141.72	136.95	105.57	132.97	141.08
Cash Conversion Cycle (Average Days)	98.14	66.62	131.2	142.46	150.09
Long Term Solvency
Total Debt/Equity	30.34	31.03	46.82	46.7	42.73
Total Debt / Total Capital	23.28	23.68	31.89	31.83	29.94
LT Debt/Equity	11.18	12.8	16.15	16.8	14.32
Long-Term Debt / Total Capital	8.58	9.77	11	11.45	10.04
Total Liabilities / Total Assets	48.57	41.35	46.57	46.56	45.09
EBIT / Interest Expense	3.49	7.09	4.36	2.59	0.85
EBITDA / Interest Expense	5.72	10.56	6.99	4.66	2.45
(EBITDA - Capex) / Interest Expense	3.6	3.18	-5.57	0.35	-1.23
Total Debt / EBITDA	1.3	1.18	2.72	2.67	4.28
Net Debt / EBITDA	1.22	1.06	2.48	2.63	2.92
Total Debt / (EBITDA - Capex)	2.07	3.94	-3.41	35.72	-8.55
Net Debt / (EBITDA - Capex)	1.93	3.53	-3.11	35.1	-5.83
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	8.51	19.52	-7.8	3.16	-1.22
Gross Profit, 1 Yr. Growth %	15.77	14.94	-2.82	9.33	-2.85
EBITDA, 1 Yr. Growth %	1.89	28.64	-21.73	1.27	-37.05
EBITA, 1 Yr. Growth %	3.93	38.59	-28.06	-7.88	-51.82
EBIT, 1 Yr. Growth %	4.06	40.86	-27.21	-4.26	-57.91
Earnings From Cont. Operations, 1 Yr. Growth %	98.84	67.93	-29.42	-29.46	-52.01
Net Income, 1 Yr. Growth %	98.84	67.93	-29.42	-29.46	-52.01
Normalized Net Income, 1 Yr. Growth %	36.55	71.13	-34.31	-23.3	-68.02
Diluted EPS Before Extra, 1 Yr. Growth %	99.08	67.77	-29.35	-29.46	-52.34
Accounts Receivable, 1 Yr. Growth %	19.71	0.99	4.84	3.32	1.98
Inventory, 1 Yr. Growth %	38.52	-28.66	51.31	6.41	8.45
Net Property, Plant and Equip., 1 Yr. Growth %	1.55	13.75	48.45	12.16	6.32
Total Assets, 1 Yr. Growth %	5.19	-0.01	30.81	5.64	14.21
Tangible Book Value, 1 Yr. Growth %	11.03	12.75	16.02	1.76	15.53
Common Equity, 1 Yr. Growth %	9.31	14.02	19.17	5.65	17.41
Cash From Operations, 1 Yr. Growth %	54.49	-23.75	-57.35	152.82	20.36
Capital Expenditures, 1 Yr. Growth %	135.06	140.84	101.6	-44.81	8.8
Levered Free Cash Flow, 1 Yr. Growth %	124.93	-157.88	380.46	-75.1	-10.81
Unlevered Free Cash Flow, 1 Yr. Growth %	71.69	-137.91	484.42	-83.01	-27.79
Dividend Per Share, 1 Yr. Growth %	-	-	-	-	-
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	9.56	13.88	4.97	-2.47	0.93
Gross Profit, 2 Yr. CAGR %	13.2	15.35	5.68	3.08	3.04
EBITDA, 2 Yr. CAGR %	28.31	14.49	0.35	-10.97	-20.26
EBITA, 2 Yr. CAGR %	48.54	20.01	-0.15	-18.59	-33.51
EBIT, 2 Yr. CAGR %	56.65	21.07	1.26	-16.52	-36.65
Earnings From Cont. Operations, 2 Yr. CAGR %	110.09	82.73	8.87	-29.44	-41.82
Net Income, 2 Yr. CAGR %	110.09	82.73	8.87	-29.44	-41.82
Normalized Net Income, 2 Yr. CAGR %	1.38K	52.87	6.03	-29.02	-50.93
Diluted EPS Before Extra, 2 Yr. CAGR %	110.07	82.76	8.87	-29.41	-42.02
Accounts Receivable, 2 Yr. CAGR %	15.97	9.95	2.9	4.07	2.65
Inventory, 2 Yr. CAGR %	15.55	-0.59	3.89	26.89	7.42
Net Property, Plant and Equip., 2 Yr. CAGR %	-2.39	7.47	29.95	29.04	9.2
Total Assets, 2 Yr. CAGR %	2.48	2.55	14.36	17.55	9.87
Tangible Book Value, 2 Yr. CAGR %	8.45	11.89	14.37	8.66	8.43
Common Equity, 2 Yr. CAGR %	6.88	11.64	16.57	12.21	11.38
Cash From Operations, 2 Yr. CAGR %	49.84	8.53	-42.48	3.84	74.44
Capital Expenditures, 2 Yr. CAGR %	-9.35	137.93	120.35	5.48	-22.51
Levered Free Cash Flow, 2 Yr. CAGR %	41.08	13.81	66.77	9.39	-52.1
Unlevered Free Cash Flow, 2 Yr. CAGR %	138.22	-19.49	48.85	-0.35	-64.87
Dividend Per Share, 2 Yr. CAGR %	-	-	-	-	-
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-0.19	12.79	6.14	4.37	-2.07
Gross Profit, 3 Yr. CAGR %	-0.69	13.78	8.94	6.89	1.05
EBITDA, 3 Yr. CAGR %	-2.7	28.42	0.86	0.65	-20.75
EBITA, 3 Yr. CAGR %	-4.34	45.14	1.19	-2.8	-31.74
EBIT, 3 Yr. CAGR %	-6.98	51.2	2.18	-0.61	-33.65
Earnings From Cont. Operations, 3 Yr. CAGR %	-1.75	94.98	33.08	-5.79	-37.95
Net Income, 3 Yr. CAGR %	-1.75	94.98	33.08	-5.79	-37.95
Normalized Net Income, 3 Yr. CAGR %	-2.18	620.97	15.36	-4.82	-45.92
Diluted EPS Before Extra, 3 Yr. CAGR %	-1.76	94.9	33.13	-5.79	-38.07
Accounts Receivable, 3 Yr. CAGR %	1.64	10.74	8.22	3.04	3.37
Inventory, 3 Yr. CAGR %	11	-1.61	14.35	4.73	20.42
Net Property, Plant and Equip., 3 Yr. CAGR %	-0.1	2.72	19.69	23.72	20.97
Total Assets, 3 Yr. CAGR %	1.32	1.64	11.22	11.38	16.45
Tangible Book Value, 3 Yr. CAGR %	5.93	9.87	13.25	10	10.9
Common Equity, 3 Yr. CAGR %	5.15	9.21	14.09	12.81	13.91
Cash From Operations, 3 Yr. CAGR %	12.09	19.63	-20.05	-5.78	9.08
Capital Expenditures, 3 Yr. CAGR %	-9.25	25.55	125.15	38.9	6.57
Levered Free Cash Flow, 3 Yr. CAGR %	77.34	4.66	83.94	-11.52	3.3
Unlevered Free Cash Flow, 3 Yr. CAGR %	39.66	28.91	55.88	-27.79	-10.32
Dividend Per Share, 3 Yr. CAGR %	-	-	-	-	-
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	7.25	7.87	1.84	6.42	4.03
Gross Profit, 5 Yr. CAGR %	8.36	8.45	1.81	9.37	6.54
EBITDA, 5 Yr. CAGR %	4.34	7.66	-1.49	10.92	-8.19
EBITA, 5 Yr. CAGR %	4.28	8.94	-2.69	15.17	-14.46
EBIT, 5 Yr. CAGR %	1.88	6.97	-3.76	19.22	-15.6
Earnings From Cont. Operations, 5 Yr. CAGR %	-4.78	5.04	2.37	29.84	-4.42
Net Income, 5 Yr. CAGR %	-4.78	5.04	2.37	29.84	-4.42
Normalized Net Income, 5 Yr. CAGR %	3.38	13.41	1.03	185.24	-18.05
Diluted EPS Before Extra, 5 Yr. CAGR %	-4.81	4.98	2.36	29.84	-4.52
Accounts Receivable, 5 Yr. CAGR %	2.08	2.04	2.14	8.03	5.95
Inventory, 5 Yr. CAGR %	16.25	0.82	8.1	8.93	11.53
Net Property, Plant and Equip., 5 Yr. CAGR %	3.45	4.47	10.98	12.53	15.38
Total Assets, 5 Yr. CAGR %	5.69	2.75	6.35	7.73	10.68
Tangible Book Value, 5 Yr. CAGR %	7.33	7.15	9.23	9.38	11.29
Common Equity, 5 Yr. CAGR %	8.23	7.96	9.58	10.4	13
Cash From Operations, 5 Yr. CAGR %	8.94	0.46	-14.16	13.43	9.23
Capital Expenditures, 5 Yr. CAGR %	11.4	5.16	29.41	17.1	46.95
Levered Free Cash Flow, 5 Yr. CAGR %	45.72	11.51	72.86	6.52	7.38
Unlevered Free Cash Flow, 5 Yr. CAGR %	24.72	31.83	43.14	16.29	-14.11
Dividend Per Share, 5 Yr. CAGR %	-	-	-	-	-